SCHEDULE 13G 0002050492 XXXXXXXX LIVE Common Stock, par value $0.01 per share 12/08/2023 0001601485 Elicio Therapeutics, Inc. 28657F103 451 D Street 5th Floor Boston MA 02210 Rule 13d-1(c) Actyus Private Equity SGIIC, S.A. U3 587818 0 517818 0 587818 N 5.45 IA Elicio Therapeutics, Inc. The Company's principal executive office is located at 451 D Street, 5th Floor, Boston, Massachusetts, 02210. This statement is filed by Actyus Private Equity SGIIC, S.A., a Sociedad Anonima organized under the laws of Spain ("Actyus" or the "Reporting Person"), with respect to the shares of Common Stock (as defined in Item 2(d) below) held by Azahar Private Capital, SCR, S.A., a Sociedad Anonima organized under the laws of Spain ("Azahar"). Actyus is the sole management company of Azahar and acts on behalf of Azahar investors' interests. The address of the business office of the Reporting Person is Calle Serrano 37, Madrid, 28001, Spain. Spain Y The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 10,791,236 shares of Common Stock outstanding as of November 8, 2024, as reported in the Company's Registration Statement on Form 10Q filed with the Securities and Exchange Commission on November 13, 2024. 5.45% 587,818 0 587,818 0 Y N See Item 2. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Actyus Private Equity SGIIC, S.A. /s/ Jasmina Armengol 01/07/2025 /s/ Alessia Carretie Columbo 01/07/2025